Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Minority Interest (2016 - 2025)

Historic Minority Interest for Arrowhead Pharmaceuticals (ARWR) over the last 15 years, with Q4 2025 value amounting to -$5.7 million.

  • Arrowhead Pharmaceuticals' Minority Interest fell 26422.83% to -$5.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$5.7 million, marking a year-over-year decrease of 26422.83%. This contributed to the annual value of $37.4 million for FY2025, which is 56495.82% up from last year.
  • According to the latest figures from Q4 2025, Arrowhead Pharmaceuticals' Minority Interest is -$5.7 million, which was down 26422.83% from $37.4 million recorded in Q3 2025.
  • In the past 5 years, Arrowhead Pharmaceuticals' Minority Interest ranged from a high of $37.4 million in Q3 2025 and a low of -$5.7 million during Q4 2025
  • Its 4-year average for Minority Interest is $12.2 million, with a median of $13.3 million in 2023.
  • The largest annual percentage gain for Arrowhead Pharmaceuticals' Minority Interest in the last 5 years was 56495.82% (2025), contrasted with its biggest fall of 26422.83% (2025).
  • Arrowhead Pharmaceuticals' Minority Interest (Quarter) stood at $19.3 million in 2022, then plummeted by 31.17% to $13.3 million in 2023, then plummeted by 73.8% to $3.5 million in 2024, then plummeted by 264.23% to -$5.7 million in 2025.
  • Its Minority Interest stands at -$5.7 million for Q4 2025, versus $37.4 million for Q3 2025 and -$2.5 million for Q2 2025.